Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Twin to twin transfusion syndrome (TTTS) is a rare complication of monochorionic twin pregnancies — pregnancies in which twins share a single placenta. Documented under Orphanet identifier 95431 and GARD identifier 325, TTTS typically develops between 15 and 26 weeks of gestation as a result of unbalanced intertwin placental anastomoses. These anastomoses create asymmetric blood flow between twins: one twin (the donor) loses blood and develops oligohydramnios (reduced amniotic fluid in its sac), while the other (the recipient) receives excess blood and develops polyhydramnios (excess amniotic fluid). Without intervention, the condition carries a high perinatal mortality rate and elevated risk of disability among survivors (Orphanet:95431). TTTS is also referred to by synonyms including feto-fetal transfusion syndrome, placental transfusion syndrome, stuck twin syndrome, and the abbreviation TTTS.
Structured phenotype data are not recorded in this packet. The condition's definition (Orphanet:95431) identifies the central manifestation as unequal amniotic fluid distribution between twins — oligohydramnios in the donor twin's sac and polyhydramnios in the recipient twin's sac — arising from disrupted placental vascular circulation between twins sharing a monochorionic placenta.
No disease-causing gene variants or inheritance patterns are documented in this packet. TTTS is not a genetic disorder; it arises from unbalanced anastomotic blood flow through the shared placenta of monochorionic twin pregnancies. The condition is an acquired prenatal vascular complication rather than a hereditary syndrome, and no molecular mechanism data are recorded in this packet.
Diagnostic methods are not described in this packet. TTTS arises in the clinical context of monochorionic twin pregnancies identified during prenatal care.
No FDA-approved drug treatments are listed in this packet for TTTS. Fetoscopic laser photocoagulation of placental anastomoses is under active clinical investigation. NCT06829901 (Baylor College of Medicine, recruiting through 2030) is evaluating uterine entry techniques for the procedure. NCT06991400 (Cincinnati Children's Hospital Medical Center, recruiting through June 2026) is evaluating laparotomy with trans-amniotic suture placement in TTTS surgery.
9 trials found
Natural history data are not included in this packet. The condition's Orphanet definition (Orphanet:95431) notes a high perinatal mortality rate and significant risk of disability in survivors when left untreated.
Eight clinical trials are recorded in this packet (ClinicalTrials.gov), including recruiting studies evaluating fetoscopic laser photocoagulation techniques (NCT06829901, Baylor College of Medicine; NCT06991400, Cincinnati Children's Hospital), cord clamping timing in preterm birth (NCT07699666, Faculty of Medicine of Tunis), and placental transfusion methods (NCT06812507, Alexandria University). A monochorionic pregnancy database study is also active (NCT05543499, University of Miami, through 2027). A total of 168 publications have been classified in the research landscape, with clinical trial publications as the dominant research type; biomarker and gene therapy publications are also represented. Patient organizations listed include the Twin to Twin Transfusion Syndrome Foundation (tttsfoundation.org) and Stichting TAPS Support (tapssupport.com).
Data assembled from 4 of 12 sources · Last updated Sep 19, 2026, 11:57 PM UTC
Patient Advocacy Groups (PAGs) provide support, resources, and community for patients and caregivers.
European rare disease database
Genetic and Rare Diseases Info Center